NMB Therapeutics, Inc
Biotechnology company · Hempstead, New York, United States
NMB Therapeutics, Inc is a biotechnology company headquartered in Hempstead, New York, United States. It has reported private securities offerings to the US SEC, most recently $60,000 sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
NMB Therapeutics at a glance
Typebiotechnology company
HeadquartersHempstead, New York, United States
SEC CIK1886659
What does NMB Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $60,000 sold (2021).
Frequently asked questions about NMB Therapeutics
Where is NMB Therapeutics headquartered?
NMB Therapeutics, Inc is headquartered in Hempstead, New York, United States.
What does NMB Therapeutics do?
NMB Therapeutics, Inc is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences